동방에프티엘(주)

{
  "address": "경기 화성시",
  "ceo_name": "정헌석, 김남기",
  "certificate": [
    {
      "cert_number": "20180107941",
      "changes": "",
      "disclosure_date": "2018-06-27",
      "first_cert_date": "2018-06-27",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2018-06-27 ~ 2020-06-26"
    },
    {
      "cert_number": "20200113557",
      "changes": "",
      "disclosure_date": "2020-10-20",
      "first_cert_date": "2018-06-27",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-06-27 ~ 2022-06-26"
    },
    {
      "cert_number": "20221020030102",
      "changes": "",
      "disclosure_date": "2022-10-20",
      "first_cert_date": "2018-06-27",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2022-10-19 ~ 2025-10-18"
    },
    {
      "cert_number": "20251112030077",
      "changes": "",
      "disclosure_date": "2025-11-12",
      "first_cert_date": "2018-06-27",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2025-10-19 ~ 2028-10-18"
    }
  ],
  "company_name": "동방에프티엘(주)",
  "corp_no": "134811-*******",
  "financials": {
    "2022": {
      "capital_stock": 3900000000,
      "cost_of_sales": 48265347000,
      "current_assets": 44910556000,
      "current_liabilities": 21680445000,
      "gross_profit": 13127256000,
      "net_income": 10760082000,
      "net_income_bs": 9855761000,
      "non_current_assets": 29300980000,
      "non_current_liabilities": 6783127000,
      "non_operating_expenses": 3089659000,
      "non_operating_income": 2438638000,
      "operating_profit": 11411103000,
      "revenue": 61392603000,
      "sga_expenses": 1716153000,
      "total_assets": 74211536000,
      "total_equity": 45747963000,
      "total_liabilities": 28463573000
    },
    "2023": {
      "capital_stock": 3900000000,
      "cost_of_sales": 53607830000,
      "current_assets": 46084223000,
      "current_liabilities": 17584427000,
      "gross_profit": 17379337000,
      "net_income": 16345014000,
      "net_income_bs": 14139765000,
      "non_current_assets": 34971650000,
      "non_current_liabilities": 7170575000,
      "non_operating_expenses": 2234321000,
      "non_operating_income": 3098179000,
      "operating_profit": 15481156000,
      "revenue": 70987167000,
      "sga_expenses": 1898181000,
      "total_assets": 81055873000,
      "total_equity": 56300871000,
      "total_liabilities": 24755002000
    },
    "2024": {
      "capital_stock": 3900000000,
      "cost_of_sales": 49452382000,
      "current_assets": 61289249000,
      "current_liabilities": 23658192000,
      "gross_profit": 13117031000,
      "net_income": 10695782000,
      "net_income_bs": 9313176000,
      "non_current_assets": 35350434000,
      "non_current_liabilities": 8320128000,
      "non_operating_expenses": 3032568000,
      "non_operating_income": 3063957000,
      "operating_profit": 10664393000,
      "revenue": 62569413000,
      "sga_expenses": 2452638000,
      "total_assets": 96639684000,
      "total_equity": 64661363000,
      "total_liabilities": 31978320000
    }
  },
  "industry": "기초 의약 물질 제조업",
  "investment": [],
  "main_products": "원료의약품,항생물질,완제의약품 제조,도소매",
  "phone": "031-354-****",
  "years": [
    2024,
    2023,
    2022
  ]
}